Sat, Jan 31, 2015, 2:31 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

CombiMatrix Corporation Message Board

pharmaapproved 268 posts  |  Last Activity: 1 hour 31 minutes ago Member since: Jun 7, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    10% rule no shorting for 2 days rule 601

    by gscgaryc Jan 7, 2015 10:03 AM
    pharmaapproved pharmaapproved Jan 7, 2015 11:30 AM Flag

    Congrats Gary, I didn't see it coming. waiting for a pullback before I take another hard look at it.
    FYI for those wondering what they heck I'm talking about: This does not pertain to ETRM

  • Reply to

    This company should be sold

    by spwangsu Jan 7, 2015 10:28 AM
    pharmaapproved pharmaapproved Jan 7, 2015 10:39 AM Flag

    One only needs to go through Marks background to see how he operates. He has started numerous companies to only sell them. ETRM will be know different in my opinion.

  • Reply to

    This company should be sold

    by spwangsu Jan 7, 2015 10:28 AM
    pharmaapproved pharmaapproved Jan 7, 2015 10:32 AM Flag

    My suspicion and it's no secret is this company will be sold! I know some don't want it sold but it will be what's best for shareholders. My guess is with approval the company will be sold for between $300Million and $500Million.

  • pharmaapproved pharmaapproved Jan 7, 2015 10:07 AM Flag

    Word is $heff and who knows how many of his 4000 followers dumped their shares on the market this morning. Couple that with weak hands, traders and you have the perfect setup for a bear raid. Long & strong as we separate the men from the boys!

  • pharmaapproved pharmaapproved Jan 6, 2015 5:57 PM Flag

    Not real sure. But if we stumbled onto anything a couple weeks ago when discussing this they have 30 days to render a decision.

  • pharmaapproved pharmaapproved Jan 6, 2015 5:42 PM Flag

    Figures. That is why I don't really follow to many people. I do have a few I follow but like to do my own DD and invest accordingly. I'm sure he probably announces his positions after the fact which is never good. Same thing with selling announce after the fact. All is fine by me people can do as they wish, but I had a feeling when I heard he was in the dominoes would fall if a decision didn't come soon enough. Heck of a way to make a killing if you can do it I guess. I checked out his page today and noticed he had a position in KBIO. Do you know if he got out of that trade? They just got hammered after-hours.

  • Reply to

    ETRM

    by pcuauhtemoc Jan 6, 2015 11:31 AM
    pharmaapproved pharmaapproved Jan 6, 2015 5:13 PM Flag

    Gulf Coast Countries, including Saudi Arabia, Kuwait, Bahrain, Qatar and the United Arab Emirates.

  • pharmaapproved pharmaapproved Jan 6, 2015 10:48 AM Flag

    I don't really follow Sheff. I just pick up his commentary from other folks on different sites mentioning some of his trades. I just picked this up from another board as well.
    "Sheff on iHub said IR person stated in early December a decision would come first few weeks of January." I wonder if he talked to them personally and this was said. Because ETRM had stated on several occasions they expected a decision by the end of 2014.

    Are you Sheff?

  • 1. The guy on ihub "sheff" and his impatient followers
    2. The hit piece from SA last week
    3. The SA article yesterday from Spencer who's not sure if he's long or short, and is now basically telling his followers not to expect much out of Enteromedics.
    4. Market sell orders (Rookies)

    Basically (as we longs know) ETRM is a thinly traded stock. Couple that with a bunch of traders who jump when someone says "BOO" we will have some wild swings. And never forget bears get hungry too, and love a coordinated attack when given the opportunity.

    DON'T FEED THE BEARS!!

  • "The neuromodulation market is the most lucrative sector of the overall neurological devices market and is poised for significant growth as new companies enter."

    "Low market penetration coupled with increased neurological procedure growth and extensive technological advancement is expected to drive the U.S. neuromodulation market, reports iData Research"

    "The neuromodulation market include spinal cord stimulators (SCSs), vagus nerve stimulators (VNSs), deep brain stimulators (DBSs), gastric electric stimulators (GESs) and sacral nerve stimulators (SNSs)."

    "Medtronic has been leading the total neuromodulation device market and has been the leader in three out of the five markets." When I hear this I think of Brad Hancock, ETRM new hire, who successfully launched New Spinal Cord Stimulator, Deep Brain Stimulator, and Programmable Pump for Medtronic. Brad exceeded operating profit and maintained margins during tenure with Medtronic. So Brad basically helped turn Medtronic into a "$70 BILLION COMPANY!"

    prwebDOTcom/releases/2014/12/prweb12414747DOThtm

    December 30, 2014

  • Reply to

    APPROVAL BY January 9th, 2015 (this week)

    by adelfig Jan 4, 2015 10:37 AM
    pharmaapproved pharmaapproved Jan 4, 2015 11:37 AM Flag

    I feel your frustration. IR is definitely hit and miss as to what they do respond to and what they don't. With that said you can probably imagine they are being bombarded with questions some which they could answer some which they can not. A far as the FDA. I believe the FDA is hell bent on finding cures/treatment for obesity. If they weren't there is no way some of the recent drug approvals would have passed. I think the slight delay if there is even one is due to the fact it's a new device. The nice thing for ETRM in my opinion is there are no long lasting harmful side effects the drugs have and VBLOC is less invasive than surgery options today. VBLOC will fill in the sweet spot between pills and the untouched device market when combating obesity.

  • pharmaapproved pharmaapproved Jan 4, 2015 11:23 AM Flag

    I think you're pretty much spot on. I believe although the initial cost will be somewhere in the ballpark you have noted, it will trickle up slightly as time passes. We have already been told there will be incentives for those who looking to have the procedure done at the initial launch.

    Older post of mine:
    I was interested in what it would cost on average for a patient who is self pay. After researching I found lap-band runs around $15,000.00. ETRM has stated the Mastero System will be competitively priced with lap-band. So then I went and found self pay patients are paying on average $220 a month from 3rd party lenders. This is interesting because this number $220 month is exactly what it cost on average for BELVIQ which we all know by now is an FDA approved drug for weight loss. My point being. You can have minimally invasive surgery and never worry about pills again, or you can take pills which "potentially" have serious long-term side effects. This is just initially though as I believe the groundwork over the past three years has been laid, and reimbursement will be somewhere in the 60% to 80% range within one to two years.

  • Reply to

    Market acceptance

    by jeffjustin306 Jan 3, 2015 4:16 PM
    pharmaapproved pharmaapproved Jan 3, 2015 4:40 PM Flag

    It's simple, there are 200,000 patients each year who need surgery yet who refuse to because they do not want their insides altered or ripped apart. The seriousness of side effects & complications with existing options will make VBLOC a huge success in my opinion. And this guy sounds like he is perfect for making this happen.

    Brad Hancock: Vice President Neuromodulation at Medtronic May 2004 – August 2008 where he Held responsibility for sales of pain and movement disorder products to Neurosurgeons, Neurologist and Interventional Pain Physicians. Tasked with delivering consistent strong revenue growth through market share gain and market development. Exceeded revenue plan in 2005, 2006, and 2007. Revenue in 2008 of 675M with a sales force of 515. Integrated the Movement Disorder and Pain divisions into a single entity. Expanded the US Sales organization by 157 managers and sales reps to support rapid growth. Successfully launched new Spinal Cord Stimulator, Deep Brain Stimulator, and Programmable Pump. Exceeded operating profit and maintained margins during tenure.

  • pharmaapproved pharmaapproved Jan 3, 2015 4:30 PM Flag

    Inns, we think alike. When approved, and if approved, I will be a buyer at anything as to what I consider cheap. Thus averaging up not down. I did however average down when presented the gift over the past few months! Good luck as we fight off these rats who are starting to appear! Must be getting close to "nitty gritty" time!

  • pharmaapproved pharmaapproved Jan 3, 2015 4:20 PM Flag

    Ade, your 6 digit share count and being here for almost 2 years explain a lot. GOOD LUCK!!

  • pharmaapproved pharmaapproved Jan 3, 2015 4:15 PM Flag

    I would give "Sierra World" about as much credibility as "Zachs."
    =================================================================================
    Northland Capital: $7 Price Target
    Price target of $7 would give the company a $400 million market cap. The company could also find itself the target of a takeover, according to Kalila. "While we can articulate on DCF's as to how our PT was achieved, we believe that Enteromedics could now be a good takeout target post-approval and post-first few quarters of launch," the analyst said. "The diabetes and obesity space are usually high takeout multiple spaces, with premiums @ 5 - 10x forward sales."
    ==================================================================================
    Roth Capital: Boost Price Target Buy $5.00
    ==================================================================================
    Canaccord Genuity: Boost Price Target Buy $5.00
    ==================================================================================
    Craig Hallum: Boost Price Target $6.00
    ==================================================================================
    Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
    Consensus Rating: Buy (Score: 2.75)
    Consensus Price Target: $4.40 (195.30% upside)

  • Providing FDA approves, and there is no buy-out of course. How many will be able to say a year from now they hold this little gem for under $2 bucks a share? That's the question you should all be asking yourselves. Are you going to be one of those who "sold on the news kicking and crying" or are you going to be one of those "Joyfully wiping all the tears from all those who sold themselves short."

  • Reply to

    SOLID support at $ 1.40 (2 months now)

    by adelfig Dec 31, 2014 1:46 PM
    pharmaapproved pharmaapproved Dec 31, 2014 2:37 PM Flag

    I can't help but notice three people on this list of insiders where employed by Medtronic when they went after "Transneuronix, Inc" in what turned out to be disastrous. So a deal with Medtronic would make perfect sense.

    Mark knudson: Restore Medical Incorporated was acquired by Medtronic, Inc.

    Luke Evnin: Metabasis Therapeutics, Inc. (acquired by Ligand Pharmaceuticals, Inc.), Oscient Pharmaceuticals Corp. and Restore Medical, Inc. (acquired by Medtronic, Inc.)

    Bobby Griffen: Retired from a 25 year career with Medtronic, Inc.

    Mr. Tremmel: He served in a variety of senior management positions at Medtronic, Inc, including President of the Neurological Division from 2003 to 2007, President of the Physio Control Division, President of the Tachyarrhythmia Management Division and President of the Interventional Vascular Division

    Brad Hancock: Vice President Neuromodulation at Medtronic May 2004 – August 2008 where he Held responsibility for sales of pain and movement disorder products to Neurosurgeons, Neurologist and Interventional Pain Physicians. Tasked with delivering consistent strong revenue growth through market share gain and market development. Exceeded revenue plan in 2005, 2006, and 2007. Revenue in 2008 of 675M with a sales force of 515. Integrated the Movement Disorder and Pain divisions into a single entity. Expanded the US Sales organization by 157 managers and sales reps to support rapid growth. Successfully launched new Spinal Cord Stimulator, Deep Brain Stimulator, and Programmable Pump. Exceeded operating profit and maintained margins during tenure.

  • pharmaapproved pharmaapproved Dec 31, 2014 12:36 PM Flag

    You want real!? This is Real!

    Quoted from the Enteromedics VBLOC ADCOM panel discussions.

    Good afternoon. My name is Mike Magnant. I live in Carver, Massachusetts. I have been overweight all of my life, experiencing a lifetime high of 293 pounds. I have always been an active person, and I'll never forget
    the day in Gloucester, Massachusetts, when I was removing my boat from the water and I became extremely winded and tired. It was at that moment I knew I had to do something. After a lifetime of diets, nutritionists, and exercise programs, I was fortunate enough to be accepted in the VBLOC trial at Tufts Medical Center, which changed my life. I received the VBLOC on Friday, December 2nd, 2011, and I returned to work three days later. On the day I received the VBLOC, I weighed in at 271 pounds. Today, two and a half years out, I weigh 215 pounds. I have lost 56 pounds. I have been able to sustain a healthy diet and have kept up with a daily exercise regimen. I also keep a food diary through an app called MyFitnessPal. My medications have been cut drastically. The last time I saw my doctor, he said that my cholesterol was on track and my blood pressure was perfect. Wow. In my entire life, I have never been able to obtain this kind of success for this length of time. In comparison, eight years ago my wife had the Roux-en-Y gastric bypass surgery. She was out of work for six weeks experiencing debilitating side effects. To this day, on a daily basis, she still experiences side effects that do not allow her to eat a normal diet and continue a normal lifestyle. My wife says her surgery saved her life, but it ruined her life. With my VBLOC, I can eat anything I want. I have never been nauseous, lightheaded, or have had any side effect

  • Reply to

    This message board is worthless

    by tallyparty Dec 31, 2014 10:54 AM
    pharmaapproved pharmaapproved Dec 31, 2014 11:19 AM Flag

    Worthless? I see you need help with you DD. Because it only takes 30 seconds to find what you're looking for. But since I'm a nice guy I will point you in a direction. Although it's not definitive look up "FDABIOCATALYST" Now scroll down and tell me what you see. Now click on the link which by the way has changed recently. I believe it said "end of year 2014" it now says "or early 2015" Anyway click on the link and read the PR from EnteroMedics it reads "As previously announced, the Company expects a decision on approval of the PMA later this year."

    Good Luck & Happy new Year!!!

CBMX
1.90+0.05(+2.70%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.